A weight loss supplement has been given the FDA's highest recall classification after being pulled from shelves in December.
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
From mislabeled allergens to major contamination scares, each incident was a reminder of how deeply food safety is woven into ...
The number of hospitalizations and deaths from foodborne illness doubled last year compared to 2023 in the U.S.
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...
The US Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades ...